台湾脑小血管病患者中杂合HTRA1突变的特征分析
研究对337例无NOTCH3突变的脑小血管病患者中的222例进行HTRA1基因Sanger测序,发现7个新杂合突变(占2.08%),均显著损害HTRA1蛋白酶活性;9例携带者的临床与神经影像特征与散发性脑小血管病相似。
要点
- 杂合HTRA1突变占台湾脑小血管病的2.08%(7/337)。
- 7个新突变均显著损害HTRA1蛋白酶活性。
- 携带者常见腔隙性梗死、脑出血、认知下降及第五至第六十年颈椎病。
核心结论
- 杂合HTRA1突变占台湾脑小血管病的2.08%(7/337),HTRA1相关脑小血管病与散发性脑小血管病的临床及神经影像特征相似。
研究设计与样本
- 对337例无NOTCH3突变的脑小血管病患者中选出的222例进行HTRA1的Sanger测序,并分析突变对HTRA1蛋白酶活性的影响。
主要发现
- 检出7个新杂合突变:p.Gly120Asp、p.Ile179Asn、p.Ala182Profs*33、p.Ile256Thr、p.Gly276Ala、p.Gln289Ter和p.Asn324Thr,每个突变各见于1例先证者。
- 所有突变均显著损害HTRA1蛋白酶活性。
- 7例先证者及另2例携带杂合HTRA1突变的患病同胞常见表现为腔隙性梗死、脑出血、认知下降及第五至第六十年颈椎病。
- 9例患者中4例有妄想、抑郁和强迫行为等精神症状,3例有前颞极白质脑病,2例有脱发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Homozygous and compound heterozygous mutations in the high temperature requirement serine peptidase A1 gene (HTRA1) cause cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. However, heterozygous HTRA1 mutations were recently identified to be associated with autosomal dominant cerebral small vessel disease (SVD). The present study aims at investigating the clinical features, frequency, and spectrum of HTRA1 mutations in a Taiwanese cohort with SVD. METHODS: Mutational analyses of HTRA1 were performed by Sanger sequencing in 222 subjects, selected from a cohort of 337 unrelated patients with SVD after excluding those harboring a NOTCH3 mutation. The influence of these mutations on HTRA1 protease activities was characterized. RESULTS: Seven novel heterozygous mutations in HTRA1 were identified, including p.Gly120Asp, p.Ile179Asn, p.Ala182Profs*33, p.Ile256Thr, p.Gly276Ala, p.Gln289Ter, and p.Asn324Thr, and each was identified in 1 single index patient. All mutations significantly compromise the HTRA1 protease activities. For the 7 index cases and another 2 affected siblings carrying a heterozygous HTRA1 mutation, the common clinical presentations include lacunar infarction, intracerebral hemorrhage, cognitive decline, and spondylosis at the fifth to sixth decade of life. Among the 9 patients, 4 have psychiatric symptoms as delusion, depression, and compulsive behavior, 3 have leukoencephalopathy in anterior temporal poles, and 2 patients have alopecia. CONCLUSIONS: Heterozygous HTRA1 mutations account for 2.08% (7 of 337) of SVD in Taiwan. The clinical and neuroradiological features of HTRA1-related SVD and sporadic SVD are similar. These findings broaden the mutational spectrum of HTRA1 and highlight the pathogenic role of heterozygous HTRA1 mutations in SVD.
引用
- Lee YC, Chung CP, Chao NC, et al. Characterization of Heterozygous HTRA1 Mutations in Taiwanese Patients With Cerebral Small Vessel Disease. Stroke. 2018. PMID: 29895533. doi:10.1161/STROKEAHA.118.021283
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。